; Bio-Reference Laboratories, Inc. (BRLI) - Financial and Strategic Analysis Review
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Bio-Reference Laboratories, Inc. (BRLI) - Financial and Strategic Analysis Review

VIEWS: 74 PAGES: 33

Bio-Reference Laboratories, Inc. (Bio-Reference) is a regional clinical laboratory that serves the greater New York metropolitan area. It offers the complete list of laboratory testing services used by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company currently operates through two clinical laboratories located in Elmwood Park, New Jersey and Valley Cottage, New York. The company also holds one andrology laboratory in New York, cytogenetics testing laboratory in Massachusetts, pathology laboratories in New York and Maryland; and one genetics laboratory in Maryland. Bio-Reference Laboratories, Inc. Key Recent Developments Aug 26, 2010 Bio-Reference Reports Net Income Of $8.01 Million In Q3 Fiscal 2010 May 27, 2010 Bio-Reference Reports Net Income Of $5.79 Million In Q2 Fiscal 2010 Dec 17, 2009 Bio-Reference Reports Net Income Of $21.8 Million In Fiscal 2009 Sep 02, 2009 Bio-Reference Reports Net Income Of $6.4 Million In Q3 Fiscal 2009 Jun 04, 2009 Bio-Reference Posts $4.6 Million Net Income In Q2 Fiscal 2009 This comprehensive SWOT profile of Bio-Reference Laboratories, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including, - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associa

More Info
  • pg 1
									               Bio-Reference Laboratories, Inc. (BRLI) - Financial and Strategic
                                     Analysis Review

       Reference Code: GDME224FSA                                                                                        Publication Date: AUG 2010

       481 Edward H. Ross Drive              Phone            +1 201 7912600                              Revenue           362.7 (million USD)
       Elmwood Park, NJ                      Fax              +1 201 7911941                              Net Profit        21.85 (million USD)
       07407                                 Website          www.bioreference.com                        Employees         1,691
       United States                         Exchange         BRLI [NASDAQ]                               Industry          Medical Equipment

      Company Overview
       Bio-Reference Laboratories, Inc. (Bio-Reference) is a regional clinical laboratory that serves the greater New York metropolitan
       area. It offers the complete list of laboratory testing services used by healthcare providers in the detection, diagnosis, evaluation,
       monitoring and treatment of diseases. The company currently operates through two clinical laboratories located in Elmwood Park,
       New Jersey and Valley Cottage, New York. The company also holds one andrology laboratory in New York, cytogenetics testing
       laboratory in Massachusetts, pathology laboratories in New York and Maryland; and one genetics laboratory in Maryland.

      Key Executives                                                                 SWOT Analysis
                     Name                                  Title                     Bio-Reference Laboratories, Inc., SWOT Analysis
       Marc D. Grodman, M.D.                Chairman                                 Strengths                    Weaknesses

       Sam Singer                           Chief Financial Officer
                                                                                     Expanding Market Share in           Billing Complications
       Howard Dubinett                      Chief Operating Officer                  the Sector
       Harry Elias                          Director                                                                     Limited Liquidity Position
                                                                                     Laboratory Testing Services
       John Roglieri, M.D.                  Director                                 Portfolio
       Source: Annual Report, Company Website, Primary and Secondary Research
       GlobalData

      Share Data                                                                     Opportunities                       Threats
       Bio-Reference Laboratories, Inc.
       Share Price (USD) as on 25-Aug-2010                               19.20       US Clinical Laboratory Testing Changing Government
                                                                                     Market                         Regulations
       EPS (USD)                                                           0.78

       Market Cap (million USD)                                             533      Rising Healthcare Expenditure Highly Competitive Market
                                                                                     in the US
       Enterprise Value (million USD)                                       556

       Shares Outstanding (million)                                             28
       Source: Annual Report, Company Website, Primary and Secondary Research
       GlobalData                                                                    Source: Annual Report, Company Website, Primary and Secondary Research
                                                                                     GlobalData


      Financial Performance                                                          Recent Developments
                                                                                     Aug 26, 2010         Bio-Reference Reports Net Income Of
                                                                                                          $8.01 Million In Q3 Fiscal 2010
                           
								
To top